Scottish Biotech and bluebird bio to Develop Next Generation CAR-T Cells – Labiotech.eu (blog)
Labiotech.eu (blog) |
Scottish Biotech and bluebird bio to Develop Next Generation CAR–T Cells
Labiotech.eu (blog) TC Biopharm has scored a deal with bluebird bio for the development of the next generation of CAR–T cells, a technology giving new hope to cancer patients. With the first two CAR-T therapies now in the market, the way we treat cancer is changing. This … Taking on gamma delta T cells, bluebird pays $16M for TC BioPharm's tumor invading tech platform bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell … Life sciences group TC BioPharm secures $16m US tie-up to develop new cancer treatments |
